Get the Stockscreener App
10.46
0.77%
0.08
After Hours:
10.50
0.04
+0.38%
Clearpoint Neuro Inc stock is traded at $10.46, with a volume of 290.27K.
It is up +0.77% in the last 24 hours and down -3.06% over the past month.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
See More
Previous Close:
$10.38
Open:
$10.38
24h Volume:
290.27K
Relative Volume:
0.36
Market Cap:
$313.65M
Revenue:
$36.97M
Net Income/Loss:
$-25.54M
P/E Ratio:
-11.59
EPS:
-0.9022
Net Cash Flow:
$-24.45M
1W Performance:
+14.07%
1M Performance:
-3.06%
6M Performance:
-57.87%
1Y Performance:
-11.21%
1-Day Range:
$10.38
$10.75
1-Week Range:
$8.27
$10.75
52-Week Range:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
10.46 | 311.25M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
(CLPT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Will ClearPoint Neuro Inc benefit from current market trendsNew Guidance & Low Risk Entry Point Guides - baoquankhu1.vn
ClearPoint Neuro (NASDAQ: CLPT) seeks approval for larger equity incentive plan - Stock Titan
Whats the analyst consensus on ClearPoint Neuro Inc2026 Setups & High Accuracy Swing Trade Signals - baoquankhu1.vn
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Update Report: Can ClearPoint Neuro Inc be the next market leaderQuarterly Profit Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Published on: 2026-04-08 04:16:27 - baoquankhu1.vn
ClearPoint Neuro, Inc. (CLPT) stock price, news, quote and history - Yahoo Finance UK
ClearPoint Neuro (CLPT) price target decreased by 10.71% to 25.50 - MSN
Why The ClearPoint Neuro (CLPT) Investment Story Is Shifting On Regulatory And Partnership Risks - Yahoo Finance
Value Recap: What are the future prospects of ClearPoint Neuro IncShort Setup & AI Enhanced Trading Alerts - baoquankhu1.vn
CLPT Technical Analysis & Stock Price Forecast - Intellectia AI
ClearPoint Neuro (CLPT) director awarded 755 shares as stock compensation - Stock Titan
ClearPoint Neuro (CLPT) director receives 1,270-share stock grant as fees - Stock Titan
ClearPoint Neuro (CLPT) director granted 442-share stock fee award - Stock Titan
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - msn.com
Short Interest in ClearPoint Neuro Surges 29% in March - National Today
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March - MarketBeat
Can ClearPoint Neuro Inc be the next market leaderEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn
What are the future prospects of ClearPoint Neuro Inc2026 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vanguard amendment shows 0% stake in ClearPoint Neuro (CLPT) after realignment - Stock Titan
Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Trading Systems Reacting to (CLPT) Volatility - Stock Traders Daily
ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan
Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - MarketScreener
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clearpoint Neuro Inc Stock (CLPT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Feb 25 '26 |
Sale |
15.17 |
19,951 |
302,657 |
193,231 |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):